Scope Fluidics Spolka Akcyjna (WAR:SCP) Revenue: zł0.10 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:SCP Scope Fluidics Spolka Akcyjna WAR:SCP
50 GF Score
Price zł118.00
GF Value zł128.09
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Scope Fluidics Spolka Akcyjna Revenue?

Scope Fluidics Spolka Akcyjna WAR:SCP -0.84% 50 Revenue is zł0.10 Mil as of Mar. 2026. GuruFocus rates WAR:SCP with a GF Score™ of 50/100 and a GF Value™ of zł128.09 (Fairly Valued). The stock has 4 warning signs investors should review.

Scope Fluidics Spolka Akcyjna's revenue for the three months ended in Mar. 2026 was zł0.03 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was zł0.10 Mil. Scope Fluidics Spolka Akcyjna's Revenue per Share for the three months ended in Mar. 2026 was zł0.01. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was zł0.12.

Warning Sign:

Scope Fluidics Spolka Akcyjna revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Scope Fluidics Spolka Akcyjna was 195.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was -40.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 10 years, Scope Fluidics Spolka Akcyjna's highest 3-Year average Revenue per Share Growth Rate was -40.20% per year. The lowest was -40.20% per year. And the median was -40.20% per year.


Scope Fluidics Spolka Akcyjna  (WAR:SCP) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Scope Fluidics Spolka Akcyjna Revenue Related Terms


Scope Fluidics Spolka Akcyjna Revenue Historical Data

* Premium members only.

The historical data trend for Scope Fluidics Spolka Akcyjna's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scope Fluidics Spolka Akcyjna Revenue Chart

Scope Fluidics Spolka Akcyjna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.40 0.52 0.13 0.10

Scope Fluidics Spolka Akcyjna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.65 0.02 -0.60 0.03

WAR:SCP vs TMO, DHR, IDXX: Revenue Comparison

For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scope Fluidics Spolka Akcyjna Revenue vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's Revenue distribution charts can be found below:

* The bar in red indicates where Scope Fluidics Spolka Akcyjna's Revenue falls into.


WAR:SCP
50GF Score
Scope Fluidics Spolka Akcyjna WAR:SCP
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scope Fluidics Spolka Akcyjna Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of zł0.10 Mil mean?
Scope Fluidics Spolka Akcyjna (WAR:SCP) has a Revenue of zł0.10 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Scope Fluidics Spolka Akcyjna and its competitors.
Is Scope Fluidics Spolka Akcyjna's Revenue too high?
Scope Fluidics Spolka Akcyjna's current Revenue is zł0.10 Mil. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's Revenue compare to TMO and DHR?
Scope Fluidics Spolka Akcyjna's Revenue of zł0.10 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Diagnostics & Research company?
A good Revenue depends on the Medical Diagnostics & Research industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. Scope Fluidics Spolka Akcyjna's current Revenue is zł0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna (WAR:SCP) is currently considered Fairly Valued. The stock's GF Value™ is zł128.09, compared to a current price of zł118.00 — trading 7.9% below its estimated fair value. The current Revenue is zł0.10 Mil. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (WAR:SCP), the current Revenue is zł0.10 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scope Fluidics Spolka Akcyjna (WAR:SCP) Overvalued in 2026?

Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued. The current stock price of zł118.00 is trading 7.9% below its estimated GF Value™ of zł128.09. GuruFocus considers Scope Fluidics Spolka Akcyjna to be Fairly Valued.

Key valuation signals for WAR:SCP:

  • Revenue: zł0.10 Mil
  • GF Value™: zł128.09 vs. price of zł118.00 (7.9% below fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the WAR:SCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scope Fluidics Spolka Akcyjna Business Description

Other Exchanges S84:Germany
Address Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
50GF Score

Get the complete analysis for WAR:SCP

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł118.00
Price
zł128.09
GF Value